We also summarize the results of anti-EGFR therapies in ovarian cancer clinical trials and discuss challenges and future work in effective treatments utilizing anti-EGFR therapies in ovarian cancer, focusing on epithelial ovarian cancer whenever possible. This evidence concerns the gene EGFR and ovarian cancer.